NO20002189L - Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon - Google Patents

Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon

Info

Publication number
NO20002189L
NO20002189L NO20002189A NO20002189A NO20002189L NO 20002189 L NO20002189 L NO 20002189L NO 20002189 A NO20002189 A NO 20002189A NO 20002189 A NO20002189 A NO 20002189A NO 20002189 L NO20002189 L NO 20002189L
Authority
NO
Norway
Prior art keywords
macrolides
mucous
degeneration
cancer
treatment
Prior art date
Application number
NO20002189A
Other languages
English (en)
Other versions
NO20002189D0 (no
Inventor
Yat Sun Or
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20002189D0 publication Critical patent/NO20002189D0/no
Publication of NO20002189L publication Critical patent/NO20002189L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20002189A 1997-10-31 2000-04-27 Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon NO20002189L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (2)

Publication Number Publication Date
NO20002189D0 NO20002189D0 (no) 2000-04-27
NO20002189L true NO20002189L (no) 2000-06-28

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002189A NO20002189L (no) 1997-10-31 2000-04-27 Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon

Country Status (17)

Country Link
EP (1) EP1027060A2 (no)
JP (1) JP2001521891A (no)
KR (1) KR20010031577A (no)
CN (1) CN1278178A (no)
AR (1) AR043071A1 (no)
AU (1) AU1206799A (no)
BG (1) BG104436A (no)
BR (1) BR9813318A (no)
CA (1) CA2307850A1 (no)
HU (1) HUP0100012A3 (no)
IL (1) IL135518A0 (no)
NO (1) NO20002189L (no)
PL (1) PL340604A1 (no)
SK (1) SK6172000A3 (no)
TR (1) TR200001147T2 (no)
WO (1) WO1999022722A2 (no)
ZA (1) ZA989885B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5037771B2 (ja) 2000-04-13 2012-10-03 バイオチカ テクノロジー リミテッド グリコシル化されたハイブリッド産物およびその産生方法と利用
WO2004027027A2 (en) 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
JP4928937B2 (ja) 2003-03-28 2012-05-09 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ ミグラスタチンアナログおよびその使用
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
CN1950388A (zh) * 2004-02-27 2007-04-18 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
WO2006001967A2 (en) 2004-05-25 2006-01-05 Sloan-Kettering Institute For Cancer Research Migrastatin analogs in the treatment of cancer
US8188141B2 (en) 2004-09-23 2012-05-29 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
CA2615990A1 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
EP3290427A1 (en) 2005-08-24 2018-03-07 Melinta Therapeutics, Inc. Triazole compounds and methods of making and using the same
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
CN106317146B (zh) * 2015-06-18 2019-06-21 沈阳药科大学 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
TR200001147T2 (tr) 2000-08-21
CN1278178A (zh) 2000-12-27
ZA989885B (en) 1999-05-05
AR043071A1 (es) 2005-07-20
JP2001521891A (ja) 2001-11-13
EP1027060A2 (en) 2000-08-16
KR20010031577A (ko) 2001-04-16
CA2307850A1 (en) 1999-05-14
WO1999022722A3 (en) 1999-08-05
PL340604A1 (en) 2001-02-12
SK6172000A3 (en) 2001-03-12
BG104436A (en) 2000-12-29
HUP0100012A3 (en) 2003-07-28
NO20002189D0 (no) 2000-04-27
IL135518A0 (en) 2001-05-20
HUP0100012A2 (hu) 2001-05-28
BR9813318A (pt) 2000-08-22
WO1999022722A2 (en) 1999-05-14
AU1206799A (en) 1999-05-24

Similar Documents

Publication Publication Date Title
NO20002189D0 (no) Anvendelse av makrolider for behandling av cancer og mukuladegenerasjon
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
FI970990A7 (fi) Syövän toteaminen ja hoito
GB9903841D0 (en) Diagnosis and treatment of cancer
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
NO991701D0 (no) HIV og cancer behandling
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
IL127739A0 (en) Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DE69836209D1 (de) Vorbeugung und behandlunhg des hepatozellulären krebses
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
FI951060A7 (fi) Formulaatioita ja hoitomenetelmiä
NO983512D0 (no) Midler for behandling og forhindring av AIDS
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
GB9811598D0 (en) Diagnosis and treatment of cancer
NO994631D0 (no) Fremgangsmaater og sammensetninger for behandling av eggstokkreft
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL141426A0 (en) Compositions and methods for the treatment of tumor
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
EE200300057A (et) Koostis vähi profülaktikaks ja raviks